KR20080074974A - 당뇨병성 신경병증을 치료하기 위한 디아릴 우레아 - Google Patents

당뇨병성 신경병증을 치료하기 위한 디아릴 우레아 Download PDF

Info

Publication number
KR20080074974A
KR20080074974A KR1020087013801A KR20087013801A KR20080074974A KR 20080074974 A KR20080074974 A KR 20080074974A KR 1020087013801 A KR1020087013801 A KR 1020087013801A KR 20087013801 A KR20087013801 A KR 20087013801A KR 20080074974 A KR20080074974 A KR 20080074974A
Authority
KR
South Korea
Prior art keywords
diabetic neuropathy
formula
combination
compound
agents
Prior art date
Application number
KR1020087013801A
Other languages
English (en)
Korean (ko)
Inventor
올라프 베베르
베른트 리들
Original Assignee
바이엘 헬스케어 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바이엘 헬스케어 아게 filed Critical 바이엘 헬스케어 아게
Publication of KR20080074974A publication Critical patent/KR20080074974A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020087013801A 2005-11-10 2006-11-09 당뇨병성 신경병증을 치료하기 위한 디아릴 우레아 KR20080074974A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05024507.5 2005-11-10
EP05024507 2005-11-10
EP05027448.9 2005-12-15
EP05027448 2005-12-15

Publications (1)

Publication Number Publication Date
KR20080074974A true KR20080074974A (ko) 2008-08-13

Family

ID=38023616

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087013801A KR20080074974A (ko) 2005-11-10 2006-11-09 당뇨병성 신경병증을 치료하기 위한 디아릴 우레아

Country Status (5)

Country Link
EP (1) EP1948144A2 (fr)
JP (1) JP2009514921A (fr)
KR (1) KR20080074974A (fr)
CA (1) CA2628881A1 (fr)
WO (1) WO2007054303A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY183969A (en) * 2012-09-25 2021-03-17 Bayer Pharma AG Combination of regorafenib and acetylsalicylic acid for treating cancer
CN117582495A (zh) 2017-06-02 2024-02-23 拜耳医药保健有限责任公司 用于治疗癌症的瑞格菲尼和pd-1/pd-l1(2)抑制剂的组合产品

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060234931A1 (en) * 2003-07-17 2006-10-19 Biggs William H Iii Treatment of diseases with kinase inhibitors
SI1663978T1 (sl) * 2003-07-23 2008-02-29 Bayer Pharmaceuticals Corp Fluoro substituirana omega-karboksiaril difenil secnina za zdravljenje ali preprecevanje bolezni instanj

Also Published As

Publication number Publication date
WO2007054303A3 (fr) 2008-03-20
EP1948144A2 (fr) 2008-07-30
CA2628881A1 (fr) 2007-05-18
JP2009514921A (ja) 2009-04-09
WO2007054303A2 (fr) 2007-05-18

Similar Documents

Publication Publication Date Title
US4681897A (en) Pharmaceutical products providing enhanced analgesia
JP4977297B2 (ja) トラマドール物質及び抗痙攣薬を含んで成る組成物
KR100236562B1 (ko) 트라마돌 및 비-스테로이드성 소염제를 함유하는 조성물
JP6197007B2 (ja) 痛み治療用の医薬配合物
US20060052370A1 (en) Methods and compositions for treating nociceptive pain
US20090306051A1 (en) Methods and compositions for the treatment of epilepsy, seizure disorders, and other CNS disorders
KR101204108B1 (ko) 5-벤질아미노살리실산 유도체 또는 이의 염의 의약 용도
ES2356093T3 (es) Combinación farmacéutica que comprende 3-(3-dimetilamino-1-etil-2-metilpropil)fenol y paracetamol.
JP2002538176A (ja) トラマドール物質および選択的ｃｏｘ−２阻害薬を含んで成る組成物
JP2023030091A (ja) ポネシモドを含有する医薬的組み合わせ
MXPA02004410A (es) Tratamiento de combinacion para la ansiedad y la depresion.
KR20080074974A (ko) 당뇨병성 신경병증을 치료하기 위한 디아릴 우레아
JP2005519936A5 (fr)
CN101304745A (zh) 用于治疗糖尿病性神经病的二芳基脲
KR102232198B1 (ko) 의약으로서 사용되기 위한 (r)-펄린돌 및 약학적으로 허용 가능한 그의 염
WO2006017354A1 (fr) Compositions d’agonistes nicotiniques et d’agents thérapeutiques et méthodes de traitement et de prévention des maladies ou des douleurs
MXPA05000791A (es) Compuestos de 1-fenil-2-dimetilaminometil ciclohexano para la terapia de sintomas depresivos, dolor e incontinencia.
MXPA02003452A (es) Tratamiento de combinacion de esclerosis multiple (em), otras condiciones de desmielinacion y neuropatia periferica, especialmente neuropatias dolorosas y neuropatia diabetica.
KR20080066948A (ko) 당뇨병성 신경병증을 치료하기 위한 디아릴 우레아
JP2008519065A5 (fr)
EP1547614B1 (fr) Composition medicinale pour inhiber l'expression d'atp-citrate lyase et son utilisation
JP2023505054A (ja) 処置方法
CN103261162A (zh) 由[2-氨基-6-(4-氟-苯甲基氨基)-吡啶-3-基]-氨基甲酸乙酯和2-[2-[(2,6-二氯苯基)-氨基]-苯基]乙酸制成的新型多组分晶体
WO2007034056A1 (fr) ASSOCIATION D'AGONISTE AUX RECEPTEURS ß3 ET D'INHIBITEURS DE LA RECAPTURE DE MONOAMINES, COMPOSITION PHARMACEUTIQUE LA CONTENANT ET SON UTILISATION EN THERAPEUTIQUE

Legal Events

Date Code Title Description
WITN Withdrawal due to no request for examination